Your browser doesn't support javascript.
loading
Inducible de novo expression of neoantigens in tumor cells and mice.
Damo, Martina; Fitzgerald, Brittany; Lu, Yisi; Nader, Mursal; William, Ivana; Cheung, Julie F; Connolly, Kelli A; Foster, Gena G; Akama-Garren, Elliot; Lee, Da-Yae; Chang, Greg P; Gocheva, Vasilena; Schmidt, Leah M; Boileve, Alice; Wilson, Josephine H; Cui, Can; Monroy, Isabel; Gokare, Prashanth; Cabeceiras, Peter; Jacks, Tyler; Joshi, Nikhil S.
Afiliação
  • Damo M; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
  • Fitzgerald B; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
  • Lu Y; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Nader M; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
  • William I; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
  • Cheung JF; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
  • Connolly KA; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
  • Foster GG; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
  • Akama-Garren E; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Lee DY; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Chang GP; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Gocheva V; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Schmidt LM; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Boileve A; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Wilson JH; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
  • Cui C; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
  • Monroy I; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
  • Gokare P; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
  • Cabeceiras P; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Jacks T; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA. tjacks@mit.edu.
  • Joshi NS; Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA, USA. tjacks@mit.edu.
Nat Biotechnol ; 39(1): 64-73, 2021 01.
Article em En | MEDLINE | ID: mdl-32719479
ABSTRACT
Inducible expression of neoantigens in mice would enable the study of endogenous antigen-specific naïve T cell responses in disease and infection, but has been difficult to generate because leaky antigen expression in the thymus results in central T cell tolerance. Here we develop inversion-induced joined neoantigen (NINJA), using RNA splicing, DNA recombination and three levels of regulation to prevent leakiness and allow tight control over neoantigen expression. We apply NINJA to create tumor cell lines with inducible neoantigen expression, which could be used to study antitumor immunity. We also show that the genetic regulation in NINJA mice bypasses central and peripheral tolerance mechanisms and allows for robust endogenous CD8 and CD4 T cell responses on neoantigen induction in peripheral tissues. NINJA will enable studies of how T cells respond to defined neoantigens in the context of peripheral tolerance, transplantation, autoimmune diseases and cancer.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Engenharia Celular / Antígenos de Neoplasias Limite: Animals / Female / Humans Idioma: En Revista: Nat Biotechnol Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Engenharia Celular / Antígenos de Neoplasias Limite: Animals / Female / Humans Idioma: En Revista: Nat Biotechnol Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos